The Effect of Daily Teriparatide versus One-Time Annually Zoledronic Acid Administration After Transforaminal Lumbar Interbody Fusion in Osteoporotic Patients
Zixiang Wang,1,* Chenyang Zhuang,1,* Weixin Chen,1 Zefang Li,2 Juan Li,1,3 Hong Lin,1,3 Dong Jian1 1Department of Orthopedics, Zhongshan Hospital, Fudan University, Shanghai, 200032, People’s Republic of China; 2Department of Orthopedics, Qianjiang Central Hospital of Chongqing, Chon...
Guardado en:
Autores principales: | Wang Z, Zhuang C, Chen W, Li Z, Li J, Lin H, Jian D |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f5e0206058684a4ca8316b1d4aa8ea7c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Transforaminal Lumbar Interbody Fusion (TLIF) for Revision of Failed Posterolateral Spinal Fusion
por: Mohammad El-Sharkawi, et al.
Publicado: (2012) -
Treatment of osteoporosis with teriparatide: The Slovenian experience
por: Kocjan Tomaz, et al.
Publicado: (2021) -
Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel A, et al.
Publicado: (2011) -
Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study
por: Lu C, et al.
Publicado: (2017) -
Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly
por: Shi C, et al.
Publicado: (2018)